Cerebrolysin
- Generic Name
- Cerebrolysin
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 12656-61-0
- Unique Ingredient Identifier
- 37KZM6S21G
- Indication
用于脑血管疾病及脑动脉硬化、脑外伤或脑卒中后遗症、大脑发育不全、老年性痴呆以及记忆力减退者。
- Associated Conditions
- Alzheimer's Disease (AD), Cerebrovascular Diseases, Craniocerebral Injuries, Stroke
- Associated Therapies
- -
CERebrolysin In CADASIL
- First Posted Date
- 2023-03-06
- Last Posted Date
- 2023-12-06
- Lead Sponsor
- Ever Neuro Pharma GmbH
- Target Recruit Count
- 30
- Registration Number
- NCT05755997
- Locations
- 🇨🇿
Motol University Hospital, Praha, Czechia
Hair Repigmentation During Cerebrolysin Therapy
- First Posted Date
- 2022-03-21
- Last Posted Date
- 2022-03-21
- Lead Sponsor
- Universidad Autonoma de Nuevo Leon
- Target Recruit Count
- 5
- Registration Number
- NCT05288465
- Locations
- 🇲🇽
Hospital Universitario. Dr. José Eleuterio González, Monterrey, Nuevo Leon, Mexico
Early Administration of Cerebrolysin on the Outcome of Patients With Acute Stroke Undergoing EVT
- First Posted Date
- 2021-11-17
- Last Posted Date
- 2021-11-17
- Lead Sponsor
- Pomeranian Medical University Szczecin
- Target Recruit Count
- 100
- Registration Number
- NCT05124353
- Locations
- 🇵🇱
Pomeranian Medical University, University Hospital no.1, Szczecin, Poland
Effects of Cerebrolysin on Level of Consciousness and Brain Metabolism in Disorder of Consciousness After Stroke: Single Center Randomized Controlled Study
- First Posted Date
- 2021-06-04
- Last Posted Date
- 2021-06-04
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 30
- Registration Number
- NCT04913831
- Locations
- 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
Efficacy of Cerebrolysin Treatment as an add-on Therapy to Mechanical Thrombectomy in Acute Ischemic Stroke.
- Conditions
- Interventions
- First Posted Date
- 2021-05-27
- Last Posted Date
- 2022-08-24
- Target Recruit Count
- 50
- Registration Number
- NCT04904341
- Locations
- 🇵🇱
Military Institute of Medicine, Warsaw, Mazowieckie, Poland
Cerebrolycin for Treatment of Covid-related Anosmia and Ageusia
- First Posted Date
- 2021-04-05
- Last Posted Date
- 2023-01-03
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 250
- Registration Number
- NCT04830943
- Locations
- 🇪🇬
Assiut University Hospitals, Faculty of Medicine, Assiut, Egypt
the Effect of Cerebrolysin on Physical and Mental Functions of Down Syndrome
- First Posted Date
- 2021-02-11
- Last Posted Date
- 2021-02-11
- Lead Sponsor
- Mansoura University Children Hospital
- Target Recruit Count
- 64
- Registration Number
- NCT04751136
- Locations
- 🇪🇬
Mansoura University Children Hospital, Mansourah, Dakahlia, Egypt
Efficacy and Safety of Cerebrolysin on Prolonged Disorders of Consciousness
- Conditions
- Interventions
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2023-05-26
- Lead Sponsor
- Konkuk University Medical Center
- Target Recruit Count
- 12
- Registration Number
- NCT04427241
- Locations
- 🇰🇷
Konkuk University Medical Center Research Coordinating Center, Seoul, Korea, Republic of
IMPULSE - StIMulation of Brain Plasticity to Improve Upper Limb Recovery After StrokE
- Conditions
- Interventions
- First Posted Date
- 2019-10-11
- Last Posted Date
- 2022-07-28
- Lead Sponsor
- Ever Neuro Pharma GmbH
- Target Recruit Count
- 4
- Registration Number
- NCT04124367
- Locations
- 🇦🇹
Klinik Pirawarth, Bad Pirawarth, Austria
Cerebrolysin and Neurodevelopment in Preterm Infants
- Conditions
- Interventions
- First Posted Date
- 2018-04-24
- Last Posted Date
- 2021-03-15
- Lead Sponsor
- Mansoura University Children Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT03506841
- Locations
- 🇪🇬
Mansoura University Children Hospital, Mansourah, El Dakahlya, Egypt
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.